Maxcyte (DI) (MXCT)

  • Change Today:
  • 52 Week High: 240.00
  • 52 Week Low: 115.00
  • Currency: UK Pounds
  • Shares Issued: 51.36m
  • Volume: 0
  • Market Cap: £62.66m
  • Beta: 0.02

Latest ShareCast News

Maxcyte continues to build on 'substantial momentum'

By Iain Gilbert

Date: Wednesday 17 Jul 2019

(Sharecast News) - Clinical-stage life sciences company Maxcyte continued to build upon its "substantial momentum" during the first half of its trading year, putting it firmly in line with expectations for the full year.

Sunday share tips: IQE, MaxCyte

By Josh White

Date: Sunday 26 May 2019

(Sharecast News) - In his 'Inside the City' column for The Sunday Times, Ben Woods looked at the effect of Donald Trump's posturing against Huawei on the chipmaking industry - particularly, wafer semiconductor technology minnow IQE.

MaxCyte begins dosing second cohort in MCY-M11 clinical trial

By Josh White

Date: Wednesday 08 May 2019

(Sharecast News) - Clinical-stage, cell-based therapies and life sciences company MaxCyte has initiated dosing for the second cohort of patients in its US phase 1 clinical trial with MCY-M11 - the lead, wholly-owned, non-viral mRNA-based cell therapy candidate from its CARMA platform - it announced on Wednesday.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.


Maxcyte (DI) Market Data

Currency UK Pounds
Share Price 122.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 240.00
52 Week Low 115.00
Volume 0
Shares Issued 51.36m
Market Cap £62.66m
Beta 0.02

Maxcyte (DI) Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Maxcyte (DI) Dividends

No dividends found

Trades for --2019

Time Volume / Share Price
0 @ 0.000p

Maxcyte (DI) Key Personnel

CEO Doug Doerfler
CFO Ron Holtz

Top of Page